-
Most Recent
Search Results
240 results for abv
AbbVie Earnings: ABBV Stock Drops 2% Despite Q2 Beats
AbbVie earnings on Friday have ABBV stock slighty lower despite the company beating EPS and revenue estimates from Wall Street.
High-Level Measures for Earnings Momentum Keep AbbVie (ABBV) a Strong Buy
Currently, AbbVie Inc (NYSE:ABBV) has a Strong Buy using Louis Navellier’s methodology for investing and his Portfolio Grader stock evaluator. ABBV has recently seen its…
AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV
AbbVie has significant challenges, but they’re also not unique ones. Sizing up the outlook leads to a slightly bullish stance on ABBV stock.
Humira Sales Help AbbVie Inc (ABBV) to a Q1 Earnings Beat
AbbVie Inc, a pharmaceuticals company, has released its earnings report for the first quarter of 2015 and it beat analysts’ estimates
AbbVie News: 5 Things for ABBV Investors to Know About Q3
AbbVie (ABBV) news for Friday includes results from the biopharmaceutical company’s earnings report for the third quarter of 2020.
This Pharmaceutical Company is Oversold and Starting to Recover
This morning, I am recommending a bullish trade on AbbVie, Inc. (NYSE:ABBV), the biopharmaceutical company.
Nasdaq May Be In For a Tumble
The Nasdaq is looking very tired and barely able to hold above its 20-day moving average.
AbbVie Inc (ABBV) Stock STILL Has Much More Room to Run Higher
ABBV stock has a lot more long-term oomph when you consider its current pipeline. Here’s why investors shouldn’t overlook AbbVie.
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q2 2024
ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
ABBV stock results show that AbbVie beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
AbbVie Is More Than Just a Portfolio of Drugs and Acquisitions
With AbbVie’s buyout of Allergan officially finalized, ABBV stock has moved significantly higher since then. However, ABBV is so much more than this headline event.
AbbVie Inc Stock Up on Strong Earnings, Guidance Update
AbbVie (ABBV) stock was up on Thursday following the release of a positive earnings report for the first quarter of the year.
Why Vale SA (VALE), Lululemon Athletica Inc. (LULU) and AbbVie Inc. (ABBV) Are 3 of Today’s Worst Stocks
AbbVie (ABBV), Lululemon Athletica (LULU) and Vale SA (VALE) led the marketwide bearish charge on Monday.
How I Found the 700% Winner Hiding Behind Every Tech Stock
Learn how smart money finds 700% gains in overlooked tech suppliers driving some of the biggest market booms in history.
Gala Makes for an Intriguing Bet, But Gamble Responsibly
While cryptocurrencies represent a tough animal to figure out, gaming-centric Gala might be able to climb above the noise.
Why Is AbbVie Stock Down Today?
AbbVie (ABBV) stock is slipping on Friday following the release of the biopharmaceutical company’s earnings report for Q1 2022.
AbbVie Inc Stock Soars on Strong Q4 Earnings Beat
AbbVie (ABBV) stock was flying high today following the release of a positive earnings report for the fourth quarter of 2017.
Why You Should Buy ABBV Stock for Income and Value
Although there could be further weakness in the AbbVie stock price in the coming months, ABBV stock belongs in a diversified portfolio.
Shinzo Abe’s Kamikaze Politics
The new prime minister promises to reflate the economy to end Japan’s stagnation. Too bad that will only add to Tokyo’s crushing debt burden.
EOLS Stock: The Big News That Has Evolus Shares Skyrocketing Today
Evolus (EOLS) stock was on the rise Friday following news that it’s no longer dealing with lawsuits from AbbVie (ABBV) and Medytox.
AbbVie Stock Has a $10 Upside Opportunity — Buy It Now
There is a $10 technical opportunity in ABBV stock just around the corner. Get on board AbbVie while the value is still reasonable.
Why Best Buy Co Inc (BBY), AbbVie Inc (ABBV), Smith & Wesson Holding Corp (SWHC) are Three of Today’s Worst Stocks
Smith & Wesson (SWHC), Best Buy (BBY) and AbbVie (ABBV) got the new trading week started on the wrong foot.
Exceptional Metrics for Sales Growth Keep AbbVie (ABBV) a Strong Buy at recent price of $116.34
AbbVie Inc’s Strong Buy recommendation is the outcome of an analytical process that is proprietary and produced results that were above average in 5 areas:…
8 – 10 of 240 results
